Cargando…
Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999357/ https://www.ncbi.nlm.nih.gov/pubmed/36262060 http://dx.doi.org/10.1210/clinem/dgac598 |
_version_ | 1784903648190398464 |
---|---|
author | Straat, Maaike E Martinez-Tellez, Borja van Eyk, Huub J Bizino, Maurice B van Veen, Suzanne Vianello, Eleonora Stienstra, Rinke Ottenhoff, Tom H M Lamb, Hildo J Smit, Johannes W A Jazet, Ingrid M Rensen, Patrick C N Boon, Mariëtte R |
author_facet | Straat, Maaike E Martinez-Tellez, Borja van Eyk, Huub J Bizino, Maurice B van Veen, Suzanne Vianello, Eleonora Stienstra, Rinke Ottenhoff, Tom H M Lamb, Hildo J Smit, Johannes W A Jazet, Ingrid M Rensen, Patrick C N Boon, Mariëtte R |
author_sort | Straat, Maaike E |
collection | PubMed |
description | CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. METHODS: A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m(2)) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m(2)) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). RESULTS: South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). CONCLUSION: South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals. |
format | Online Article Text |
id | pubmed-9999357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99993572023-03-11 Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes Straat, Maaike E Martinez-Tellez, Borja van Eyk, Huub J Bizino, Maurice B van Veen, Suzanne Vianello, Eleonora Stienstra, Rinke Ottenhoff, Tom H M Lamb, Hildo J Smit, Johannes W A Jazet, Ingrid M Rensen, Patrick C N Boon, Mariëtte R J Clin Endocrinol Metab Clinical Research Article CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. METHODS: A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m(2)) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m(2)) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). RESULTS: South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). CONCLUSION: South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals. Oxford University Press 2022-10-20 /pmc/articles/PMC9999357/ /pubmed/36262060 http://dx.doi.org/10.1210/clinem/dgac598 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Article Straat, Maaike E Martinez-Tellez, Borja van Eyk, Huub J Bizino, Maurice B van Veen, Suzanne Vianello, Eleonora Stienstra, Rinke Ottenhoff, Tom H M Lamb, Hildo J Smit, Johannes W A Jazet, Ingrid M Rensen, Patrick C N Boon, Mariëtte R Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title | Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title_full | Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title_fullStr | Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title_full_unstemmed | Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title_short | Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes |
title_sort | differences in inflammatory pathways between dutch south asians vs dutch europids with type 2 diabetes |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999357/ https://www.ncbi.nlm.nih.gov/pubmed/36262060 http://dx.doi.org/10.1210/clinem/dgac598 |
work_keys_str_mv | AT straatmaaikee differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT martineztellezborja differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT vaneykhuubj differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT bizinomauriceb differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT vanveensuzanne differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT vianelloeleonora differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT stienstrarinke differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT ottenhofftomhm differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT lambhildoj differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT smitjohanneswa differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT jazetingridm differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT rensenpatrickcn differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes AT boonmarietter differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes |